2
0
1
8
A
N
N
U
A
L
R
E
P
O
R
T
focus 2
0
1
8
A
N
N
U
A 11
L
R
E
P
O
R
T
Board of
TRUSTEES EXECUTIVE COMMITTEE Dr. James (Jamo) Rubin, Chairman
Mr. John R. (J.R.) Hurd
Chief Executive Officer, TAVHealth
Chair, Hurd Enterprises, Ltd.
Dr. C. Collins (Andy) Anderson III, Vice Chairman
Mrs. Abigail G. Kampmann
Managing Partner, Windgate Partners, LLC
Chief Executive Officer, Principle Auto
Mr. James B. (Jamie) Smith, Secretary
Mr. John C. Kerr
Vice Chairman – Texas, Dykema Cox Smith
Mr. Richard T. (Dick) Schlosberg III (Retired) Publisher and CEO, Los Angeles Times
Mrs. Marsha M. Shields Manager, McCombs Family Partners, Ltd.
Principal, Moorman Kerr Interests
Dr. James (Jamo) Rubin Chairman
TRUSTEES Mr. Rex Amini Managing Director, Sage Energy Co.
Mr. Edward H. Austin, Jr. Principal, Austin Family Investments
Mr. Richard N. Azar II General Partner, Sezar Energy, L.P.
Mr. Craig Boyan President & Chief Operating Officer, H-E-B
Mr. Robert M. (Bobby) Cavender President, Cavender Auto Group
Ms. Phyllis Slick Cowell President, Slick Enterprises
Mrs. Barbara B. Dreeben Mr. Walter Embrey Chief Executive Officer, Embrey Partners, Ltd.
Mr. John W. Feik Chief Executive Officer, Feik Enterprises, LLC
Mr. Richard Kardys (Retired) Wealth Advisor Senior Officer, Frost Bank
SPECIAL TRUSTEES
TRUSTEES EMERITUS
Mr. Adam L. Hamilton
Dr. Ronald K. Calgaard
President & CEO, Southwest Research Institute
Mr. William R. (Bill) Klesse
Dr. Taylor Eighmy President, UTSA
Mrs. Carolyn H. Labatt
Dr. Andrea Giuffrida
Chief Executive Officer, Computer Solutions
(on behalf of Dr. William L. Henrich)
Vice President for Research and Professor, UTHealth San Antonio
Mr. Mark Pitman Mays Principal, Rocking M Capital
Mr. Joe C. McKinney
EX-OFFICIO TRUSTEE
Vice Chairman, Broadway National Bank
Ms. Callie Price President, Founder’s Council
Mr. Lewis J. (Lew) Moorman IV
Mr. Al Philip
Entrepreneur
President, The Argyle
Dr. Dacia Napier
Ms. Jody Lutz
Radiologist
President, Texas Biomedical Forum
Mr. Charles (Chuck) Urschel Slick Partner, Slick Enterprises
HONORARY TRUSTEE
Mr. John B. Zachry
Dr. John P. Howe, III
Chairman and CEO, Zachry Group
Retired President/CEO, Project HOPE
Mrs. Ashley Hixon
Hixon Family Office 2
Chairman, Ray Ellison Grandchildren Trust, The Abbey
Mr. James W. Gorman, Jr. Investor/Rancher
Mr. William E. Greehey Chairman, NuStar Energy, L.P.
Mr. Milton B. Lee (Retired) CEO, CPS Energy
Mr. B.J. McCombs Chairman, McCombs Enterprises
Mr. William G. (Bill) Moll (Retired) CEO, KLRN (Retired) Chairman & CEO, Clear Channel Television
Mr. Edward E. Whitacre, Jr. Chairman Emeritus, AT&T
Table of
CONTENTS 4 6 12 16 18 19 20 22 23 27 29 32 3
PRESIDENT’S LETTER
CHANGING LIVES IMPACTED BY INFECTION
DEEPAK KAUSHAL, NEW DIRECTOR OF THE SNPRC
COMMUNITY OUTREACH: BUILDING A CITY OF SCIENCE
ASSEMBLING THE FUTURE
FINANCIALS
GRANTS AND CONTRACTS
TEXAS BIOMED CONTRIBUTIONS
CIRCLES OF GIVING
TEXAS BIOMED FORUM
THE FOUNDER’S COUNCIL
THE ARGYLE
From the
PRESIDENT Fighting Infection TEXAS BIOMED’S NORTH STAR
U
talent and resources into supporting the entire research pipeline from early stage discovery through to diagnostics, therapies and cures for the benefit of mankind. This legacy continues.
sed as a noun, the word focus means “an act of concentrating interest or activity on something.” Last year, Texas Biomedical Research Institute defined its scientific area of focus as infectious diseases and hired new talent, created new science and outreach programs and launched our campus transformation projects as part of our bold, 10-year strategic plan.
Author and businessman Zig Ziglar once said, “I don’t care how much power, brilliance or energy you have, if you don’t harness it and focus it on a specific target, and hold it there you’re never going to accomplish as much as your ability warrants.”
According to the World Health Organization, half-a-million cases of drug resistant TB are reported annually. Every minute, a teenage girl in sub-Saharan Africa gets HIV. In 2017, 210 million people were stricken with malaria; 1/3 of surgical patients get a postoperative infection; 51% can be antibiotic resistant “superbugs.” Sepsis accounts for more than 50% of hospital deaths in the United States according to a December 2018 study published in the journal “Critical Care Medicine.” We are currently suffering from the largest number of cases of measles in 25 years. Finally, we have increasing susceptible populations, especially the elderly and those with diabetes. More and more, we are finding links between infection and diseases like heart disease, cancer and Alzheimer’s.
Texas Biomed’s foundational mission calls for us to harness our power of discovery and direct it. Since its founding in 1941 by Thomas B. Slick, Jr., the Institute has been putting its energy, time,
Texas Biomed’s mission is to innovate and share scientific breakthroughs to protect you, your families and our global community from infectious diseases. We do that by identifying
This focus has bolstered attention on the global challenges of infectious diseases and on the solutions Texas Biomed offers to meet these challenges.
4
and solving these problems faster and smarter than anybody else. Our uniqueness lies in our vision, our people and our business practices. We have combined assets and expertise on one campus that can’t be found elsewhere in the world; we are vertically integrated in our approach to science from bench to bedside, and we are a nonprofit that runs much like a for profit business — nimble and fast. This approach is by design, so we can accomplish science more efficiently and effectively with greater attention on the benefit to mankind. In this year’s annual report, we outline specific programmatic resources we are dedicating to our mission, new scientists we have added to our growing research team, campus-wide renovation projects aimed at equipping our scientists with the latest and greatest assets, as well as new programs we have begun to help educate our community and the next generation of scientists. San Antonio is a unique city in which to work thanks to its pioneering spirit, its history and the generosity of the community. This community’s support is critical to our future growth and success, because the community — each of you — is why we exist. As always, we appreciate your continued partnership and backing as we execute our mission. Science contributes to our understanding of the world around us; it provides comfort and makes life easier; it is a means to an end… better lives for generation after generation. Texas Biomed’s focus and the transformation it is undergoing underscores the commitment and dedication our team has to accomplishing the goal of enhancing lives through discovery.
Larry Schlesinger, M.D. President and CEO
5
Janeli Castrejana with her husband Jacob and three children.
Changing Lives
IMPACTED BY INFECTION
M
ornings are busy at the Castrejana household. With three children to cart to school before she heads to work, Janeli Castrejana has gotten good at multitasking. The 30-year-old San Antonian always dreamed of becoming a mother. A health crisis in her early 20s could have robbed her of having a family.
Thanks to compassionate caregivers and breakthroughs in scientific research, the HIV virus is undetectable in Janeli’s system. Janeli is not cured, but she controls her disease with medications. She became a parent without transmitting the virus to her unborn babies. “It felt like a miracle,” Janeli added.
Janeli contracted HIV, the virus that causes AIDS, when she was only 21. “I was devastated,” she said. “I thought my life was over. I thought I was going to die.”
Infectious diseases of many varieties are on the rise. The World Health Organization reports infectious diseases kill more than 17 million people a year. Thirty new diseases have emerged in the last 20 years.
2018 saw some amazing strides in the fight against infectious diseases, some of which were made by our scientists at Texas Biomed. For example, Professor Jean Patterson, Ph.D. and Professor Suzette Tardif, Ph.D., took part in a collaborative study that demonstrated the Zika virus may be triggering miscarriages and stillbirths while going undetected.
The enemies are stealthy — viruses, bacteria, fungi, parasites. They infect. They spread. They evolve. Science must keep up.
Tuberculosis (TB) researchers Dr. Schlesinger and Staff Scientist Eusondia Arnett, Ph.D., found promising experimental cancer
The AIDS epidemic has killed 35 million people since it began in the 1980s. More than 40 million people in the world are infected with HIV today.
THE FIGHT IS UNDERWAY
7
“Combating infectious diseases is one of the most important health issues of our time,” said President/CEO Larry Schlesinger, M.D. “While research has helped stop the spread of many infectious pathogens and reduced human suffering, science still has a long way to go to conquer these serious health threats.”
chemotherapy drugs may help knock out TB. Teaming up with a commercial biopharmaceutical company, Texas Biomed scientists are helping test a promising treatment for Ebola virus. Our specialists in malaria are working to find out why the mosquito-borne parasites that cause the disease are becoming drug resistant. “2018 was a strong year with regard to grant and contract submissions and awards, groundbreaking research, and high impact publications from our faculty at Texas Biomed,” said Professor and Vice President for Research Joanne Turner, Ph.D. Using our population of nearly 2,500 animals at the Southwest National Primate Research Center on campus, scientists are developing new models for liver cancer, testing an experimental hepatitis B vaccine and scanning the brains of baboons to help pinpoint a biomarker for mental illness. Our researchers have developed the marmoset as a new and crucial animal model to study aging and infectious disease.
FOCUS ON THE FUTURE In 2018, Texas Biomed built on its strengths and focused on the future with a new 10-year
AS OUR POPULATION AGES AND OTHER CHRONIC CONDITIONS LIKE DIABETES COMPLICATE HEALTH ISSUES, MORE PEOPLE WILL HAVE WEAKER IMMUNE RESPONSES TO FIGHT OFF THESE BURGEONING HEALTH THREATS.
Strategic Plan. This plan has become the Institute’s road map for growth. The plan includes the expansion of research to include other threatening infectious diseases impacting human health. Common hospital infections like MRSA and sepsis kill thousands of men and women before their time. Food-borne illnesses cause untold suffering. The dream for a better influenza vaccine is still unrealized. As our population ages and other chronic conditions like diabetes complicate health issues, more people will have weaker immune responses to fight off these burgeoning health threats. A recent report commissioned by Texas Biomed from economic development researcher TEConomy concluded “basic
8
science is where key developments in infectious disease innovation will continue occurring for the foreseeable future.” We have begun the process of recruiting new teams of top tier scientists and their research groups with complementary expertise dedicated to collaborative scientific research. As part of our focus, we’ve created three inter-related scientific programs: Host Pathogen Interaction, Disease Intervention & Prevention and Population Health. The Host Pathogen Interaction program focuses on the biology of infection and the relationship between the body and the pathogen. Program Lead and Assistant Professor Ian Cheeseman, Ph.D., explained the three new growth areas within this program include the study of vectors (like
(l to r) Ricardo Carrion, Jr., Ph.D., Program Co-lead; Shelley A. Cole, Ph.D., Program Co-lead; Jordi Torrelles, Ph.D., Program Lead; Ian Cheeseman, Ph.D., Program Lead; Luis Giavedoni, Ph.D., Program Co-lead; Timothy Anderson, Ph.D., Program Lead
9
A 3-D rendering of HIV virus in the blood stream. Acquired immunodeficiency syndrome (AIDS) is a chronic, potentially life-threatening condition caused by the human immunodeficiency virus (HIV).
mosquitoes) that carry disease, mucosal immunology (areas of attachment of pathogen) and developing and using new models of infectious diseases. “To identify the next major discoveries which transform human health, we need a better fundamental understanding of how a disease is controlled by a host, transmitted by a vector or exacerbated by a pathogen,” Dr. Cheeseman said. “This requires a multipronged approach where we build realistic models of infection combining animal and laboratory methods, probe the sites of invasion and infection in the human body and study the genetic variation in the hosts, pathogens and vectors driving disease outcomes.” The Disease Intervention and Prevention program focuses on the development of new ways to diagnose, treat and vaccinate against diseases to reduce the effects of the illness or cure it. Program Co-lead and Professor Ricardo Carrion, Jr., Ph.D. said this program will grow in areas related to multi-drug resistance and hospital-acquired infections, experimental diagnostics and therapeutics and next generation vaccines. “The Disease Intervention and Prevention program provides an environment that fosters collaboration and synergy within
the Institute’s current research areas of vaccine and therapeutic development, while spurring research in new growth areas such as multidrug resistant pathogens and hospital-acquired infections,” Dr. Carrion explained. “The critical mass of scientists working alongside each other in these fields in an atmosphere that strives for excellence will bolster Texas Biomed as a leader in infectious disease research.” Population Health will focus on how factors like DNA, age, nutrition and co-infections impact susceptibility to disease. Program Co-lead and Associate Professor Shelley Cole, Ph.D., outlined the three growth areas of this program as how the genes of individuals in a population may increase their susceptibility to infection, risk of infection due to other health conditions and the role the environment plays in the development of infectious diseases. “Population Health is a key component of biomedical research in that population health studies are used to define problems of public health importance, to determine and characterize potential causes and modifiers of a disease in the population and to demonstrate the effectiveness of prevention and intervention approaches,” Dr. Cole said.
11
To create an environment where these scientific programs can flourish — and to accommodate our growing team — plans have been laid out for structural changes that will enable the expansion of our staff and update the aging campus. Some of the construction is well underway, as highlighted on page 18.
SCIENCE GIVES US A FUTURE For millions of people around the world like Janeli Castrejana, Texas Biomed’s focus on infectious diseases is a source of hope for the future. “I am eternally grateful to the researchers who work tirelessly on new therapeutics for HIV-positive patients,” she says. “Because of them, I am the mother of three HIVnegative children.” 77 years ago, the bold founder of Texas Biomed, Tom Slick, Jr., had a vision. He believed “the welfare of mankind can be best advanced through the scientific endeavor.” The power of discovery through focused biomedical research will improve the human condition. Our focus honors Slick’s vision.
Deepak Kaushal, Ph.D.
NEW DIRECTOR OF THE SNPRC
D
eepak Kaushal, Ph.D., is a Professor at Texas Biomedical Research Institute and the new Director of the Southwest National Primate Research Center (SNPRC). He oversees the SNPRC operations, a more than $40 million National Institutes of Health-funded national resource for primate research. Dr. Kaushal is also one of the top most-funded researchers by the NIH in the United States. His research focuses on tuberculosis (TB), a disease that claims two million lives a year. Although Dr. Kaushal’s list of achievements and contributions to research are impressive, a career in the lab wasn’t always his dream. In fact, Dr. Kaushal once saw himself attending medical school after earning his undergraduate degree. Instead, he decided to pursue a master’s degree in Biochemistry at
the University of Delhi in India, his home country. During his master’s program, Dr. Kaushal was introduced to a group of young, driven scientists who had just come back from their research training in the United States. He was inspired by their intellectual curiosity and dedication to research. It was this connection that inspired Dr. Kaushal to consider a future in the lab.
Upon graduating, he became a Fogarty Foundation International Post-doctoral fellow at the Johns Hopkins University School of Medicine Center for Tuberculosis Research. Dr. Kaushal chose to focus his research on TB because he enjoyed the challenge of combating the number one infectious disease killer in the world. He remains determined to find a vaccine or set of drugs to control transmission of TB.
BECOMING A SCIENTIST
“If you look at how many people TB has killed over the course of human history versus how many people malaria has killed, or AIDS, or syphilis and you put all of these deaths together, TB has killed a thousand-fold more people in the history of mankind,” Dr. Kaushal said.
Dr. Kaushal pursued his newfound interest in research by earning his Ph.D. in Biochemistry at the University of Delhi.
In 2001, Dr. Kaushal took his passion for TB research to St. Jude Children’s Research Hospital Center for Bioinformatics and
“They had very dynamic and different views about how to conduct research,” Dr. Kaushal said. “Their viewpoints encouraged me, and I found my niche.”
12
13
Biotechnology. Then in 2006, Dr. Kaushal moved to Louisiana to accept a faculty position at the Tulane National Primate Research Center, where he advanced his research through the use of nonhuman primate models. Throughout his 13 years at Tulane University, Dr. Kaushal rose through the ranks to become the Director of the Tulane Center for TB Research and a Professor of Microbiology & Immunology.
A NEW PLACE TO CALL HOME While Dr. Kaushal enjoyed his time in the university environment, he craved a new challenge. He wanted to provide more leadership while continuing to mentor others and advance his research. When TB researcher Larry Schlesinger, M.D., became the new President and CEO of Texas Biomed in 2017, Dr. Kaushal started to consider moving his lab to San Antonio. With Dr. Schlesinger’s support and the construction of a new 7,500 square foot facility complete with a Biosafety Level-3 (BSL-3) lab where TB research can be safely conducted, Dr. Kaushal decided to make Texas Biomed his new home in the fall of 2018. His position as Director of the SNPRC gave him the leadership opportunity he was looking for.
(l to r) Shashank Ganatra, M.B.B.S., Riti Sharan, Ph.D., Tae Hyung Lee, Ph.D., Ayan Chatterjee, Ph.D., Deepak Kaushal, Ph.D., Dhiraj Singh, Ph.D., Alyssa Blakley, Danicke Willemse, Ph.D., Abigail Fish, Ph.D. “I have uninterrupted energy and enthusiasm for the job,” Dr. Kaushal said. “I think the previous director Dr. Robert Lanford has done a fantastic job of leading the SNPRC, and I think I have the initiative and vision to continue this growth.” Additionally, the SNPRC’s diverse population of nonhuman primates opened the door for new research opportunities for Dr. Kaushal. At Tulane University, Dr. Kaushal primarily worked with rhesus
14
macaques. At the SNPRC, he has the chance to use marmosets, baboons, and other species of macaques as animal models to investigate various concepts of TB. The research opportunities at Texas Biomed and the SNPRC was also appealing to Dr. Kaushal’s research team, including Dr. Dhiraj Kumar Singh, a postdoctoral scientist who followed Dr. Kaushal from Tulane University. However, the potential for research advancements wasn’t the only
appealing aspect of continuing to work with Dr. Kaushal. “Dr. Kaushal sees more talent in us than we see in ourselves,” Dr. Singh said. “He provides all the mentoring, support and motivation needed to push us to our peak performance, enabling us to excel in all dimensions of life, professional and personal alike. Who would not want to learn and be trained by such a wonderful mentor? Henceforth, when provided with the opportunity to follow Dr. Kaushal to Texas Biomed, I didn’t give it a second thought.”
animal husbandry and customer service. Dr. Schlesinger believes Dr. Kaushal is a skilled scientist who can achieve this goal. “The primate center is a flagship enterprise here at Texas Biomed,” Dr. Schlesinger said. “I was looking for a dynamic leader with great ideas and the desire to continue to elevate the stature of the primate center both nationally and internationally. Deepak is a great fit and has hit the ground running. He is a fabulous scientist and a strong leader.” When Dr. Kaushal isn’t in the lab or office, he is with his family. Dr. Kaushal is a proud
FUTURE GOALS With the incredible teamwork, integrity and diversity of Texas Biomed, Dr. Kaushal sees potential for growth at the Institute and the SNPRC. For example, he hopes to obtain more transformative technologies, such as the recently acquired endoscope, so researchers at Texas Biomed can continue to advance their infectious disease research without having to consult outside sources. He also sees a future with more collaborative opportunities with scientists in and outside Texas Biomed.
Tuberculosis infection inside the lung.
However, Dr. Kaushal’s ultimate goal is to be “known as the best NPRC” when it comes to cost-effectiveness, safety,
15
husband and father of two children who are both in high school. He has diverse interests in culture, music and the arts and even enjoys a cricket game every once in a while. Texas Biomed and the SNPRC are proud to be the new home of one of the most outstanding and dedicated TB researchers in the nation. “We look forward to more extraordinary scientific discoveries and continued growth of the SNPRC,” Dr. Schlesinger said. “We are lucky to have a multi-talented scientist such as Dr. Kaushal.”
Community Outreach
BUILDING A “CITY OF SCIENCE”
A
s today’s research leaders at Texas Biomedical Research Institute work to diminish the threat of infectious diseases, Texas Biomed’s community outreach program educates tomorrow’s scientists who will continue this good work.
said Kelli Oberheu, Science Department Chair and Biomedical Science Teacher of Harmony Public School. “Being able to talk with individuals doing research and those working with the animals was very exciting. I love that the students are so interested in science and the research that is happening so close to them.”
Texas Biomed has expanded its community outreach efforts in various ways. Since March 2018, we have successfully doubled tours for high schools, college groups and businesses. These tours include educational presentations from scientists, veterinarians and other professionals across campus, as well as a virtual tour of our Biosafety Level-4 laboratory and an up close look at the nonhuman primates in the Southwest National Primate Research Center. These tours impacted more than 1,000 visitors in 2018, including hundreds of local students.
Texas Biomed has made significant strides to develop more STEM (Science, Technology, Engineering, and Math) partnerships in the community with outreach to business and educational groups and even arts organizations. At science fairs, students are taught the importance of animal research from animal caretakers, and they learn about the various pathogens our scientists work with through hands-on activities.
“Our connection with Texas Biomed has been extremely inspirational to our students,”
“At Girls Inc, we work every day to connect young girls to local STEM professionals so that they can see all of the amazing opportunities available for them,” said Heather Aguillon, STEM Program Manager
16
for Girls Inc. of San Antonio. “Being able to engage with industry partners like Texas Biomed is a great way for kids to meet, talk to and work with someone who just might change the trajectory of their life.” Other projects have included coordinating with local organizations such as The Public Theater of San Antonio. The Public Theatre hosted a special night for Texas Biomed at its Spring showing of Rent, a Broadway musical focused on those suffering from HIV at the height of the epidemic. The evening included an audience discussion after the performance with representatives from Texas Biomed, The Public Theater and the San Antonio AIDS Foundation. “The partnership with Texas Biomed and The Public Theater has exceeded my expectations,” added Shelly Chance, Chief Operating Officer and Managing Director of the San Antonio Public Theatre. “It is wonderful for the theater to start a conversation about science and have the expertise of scientists to elevate
the conversation with real time research and progress. I am so impressed with Texas Biomed’s work, growth, and dedication to ensuring the world is a healthier place for all of us. The campus is warm and inviting, and it is vividly clear everyone performs their jobs with great care and dignity.” Community outreach is a perpetual effort to foster awareness and engagement. Ultimately, outreach efforts are a way to connect our community with science and foster an appreciation for and a desire to pursue science education. Expansion of our outreach efforts is critical to the Institute’s overall growth. Through community outreach projects, we reach thousands of innovative minds that may hold the key to the next scientific breakthrough. As we look to the future, Texas Biomed is undoubtedly becoming a critical partner in San Antonio’s STEM ecosystem to build a “City of Science.”
Texas Biomed has participated in Girls, Inc.’s RockIt Into the Future Science Festival for two years, bringing biomedical research to our next generation of scientists.
17
ASSEMBLING THE FUTURE
C
hange is in the air on the Texas Biomed campus. Three large construction projects consumed the Operations Team in 2018. Each of these improvements creates laboratory and animal space that allows for continued growth of our scientific endeavors.
NEW BSL-3 LABORATORY The new Biosafety Level-3 (BSL-3) laboratory opening Summer 2019 includes 7,500 square feet of space. Assistant Vice President for Operations, Matt Majors, describes it as “an exciting lab. This is the first of its kind for Texas Biomed, and there are very few labs like this in the country. We’re making major investments to improve efficiency, effectiveness, and customer service.” BSL-3 laboratories are high containment spaces where scientists work on communicable diseases that are serious and transmittable, but treatable, like tuberculosis. The facility will hold several new technologies Texas Biomed has not had before, like an aerosol biology room to mimic natural paths of infection with pathogens, a PET CT room,
a necropsy suite, and a huge autoclave which sterilizes equipment and cages. With so much space, the new BSL-3 will be able to house up to 80 nonhuman primates and 2,500 mice. The facility will also have amenities for the scientists including showers and a changing room. “This state-of-the-art BSL-3 facility will provide Texas Biomed researchers and collaborators with a unique platform to test novel therapies and vaccines against deadly infectious diseases such as tuberculosis, explained Professor Jordi Torrelles, Ph.D., BSL-3 Director. “With capacity to hold 25 researchers working at once and a large and diverse number of animals (mice, marmosets, macaques, baboons), this facility will provide unique venues for contract studies and foster new collaborations within San Antonio and with the U.S. and global scientific community.”
NEW MARMOSET HOUSING The James R. Dougherty, Jr., (JRD) Medical Research Laboratory has been converted into updated, expanded space for the Southwest National Primate Research Center’s colony
18
Texas Biomed’s new BSL-3 is set to open summer 2019, providing scientists new state-of-the-art equipment and facilities. of marmosets. These are small New World monkeys that serve as important animal models for aging and infectious disease studies. The interior renovation of the JRD building is a $2.5 million investment. Much of the work is mechanical. At full capacity, this 12,000 square foot building can house up to 550 marmosets, and will start with 450 marmosets, making it the country’s largest captive colony of these monkeys dedicated to biomedical research. “The construction and improvement of the JRD building will enhance the care and housing capacity for the marmosets, providing specialized barrier space to care for geriatric marmosets, and a new dedicated cage wash,” explained Associate Professor Corinna Ross, Ph.D., of the SNPRC. “These
FINANCIALS 2018 REVENUE
2018 VALUE OF ENDOWMENT
BASED ON 2018 AUDITED REPORT*
IN MILLIONS OF DOLLARS 58.1% Federal Grants 1.6%
$130
Non-Federal Grants
$125.1 $117.4 $118.3
$120
$111.5
$114.6 $107.2
17.5% Federal Contracts $100.8
$100 $93.2
5.1%
Commercial Contracts
0.8% 8.9%
Non-Federal Contracts Restricted Contributions
5.2% 2.5% 0.3%
Unrestricted Contributions Royalty Income Other Income
$91.4
$80
$60
2010
2011
2012
2013
2014
2015
2016
2017 2018
* Compared to years past, revenue excludes investment income due to market decline at the end of 2018. With the market rebound in 2019, investment income and endowment value have both increased.
facilities will help SNPRC meet the needs of the national marmoset research community.”
NEW BSL-4 ANNEX Also in 2018, crews began the site prep stage and pouring of the foundation for an annex
connecting to the Biosafety Level-4 (BSL-4) laboratory. BSL-4 is a high containment lab where scientists work on diseases for which there is no cure. This mechanical room expansion is about 2,600 square feet and will house new breathing air compressors and additional mechanical support equipment.
19
The annex, to be completed in 2019, will allow Texas Biomed to maintain the current BSL-4 while construction continues on a Master Plan which includes a brand new level 4 high containment lab in the future.
GRANTS AND CONTRACTS
Awarded in 2018
COMMERICIAL GRANTS
PRINCIPAL INVESTIGATOR
SPONSOR AND TITLE
THEVAX CORPORATION HBV Vaccine Study in Baboons
Dr. Christopher Chen
UFOVAX LLC Development and Evaluation of HIV-1 UFO Trimer Presenting Nanoparticles
Dr. Robert Lanford
JANSSEN PHARMACEUTICALS, INC. Janssen Nonfederal: Analysis of 120 Non-Human Primate samples of study 20129586 in the Ebola Zaire
Dr. Luis Giavedoni
LENGTH
1 year
2 years
1 year
NEW AWARD TOTAL
SPONSOR AND TITLE
$291,238
$1,403,796
$68,161
Total from Commercial Research: $1,763,195 FEDERAL RESEARCH GRANTS
PRINCIPAL INVESTIGATOR
LENGTH
NATIONAL INSTITUTES OF HEALTH (NIH)/U OF N-LINCOLN Mucosal Delivery and Retention of Ebola Inhibitor Scytovirin Using Lactobacillus
Dr. Ricardo Carrion
1 year
$94,972
NIH — IL-10 as a host modifier of PZA activity
Dr. Joanne Turner
2 years
$239,375
SPONSOR AND TITLE
NEW AWARD TOTAL
NIH/WYOMING Womb to Tomb: Developmental Programming and Aging Interactions in Primates
Dr. Melanie Carless
5 years
$65,415
NIH/WYOMING Womb to Tomb: Developmental Programming and Aging Interactions in Primates
Dr. Robert Lanford
5 years
$3,813,940
NIH Epigenetics of energy homeostasis, bioenergetics and obesity
Dr. Melanie Carless
5 years
$3,378,488
NIH/IOWA Mechanisms and consequences of Plasmodium/Ebola virus co-infections
Dr. Olena Shtanko
2 years
$114,900
NIH Impact of Tat-binding Cellular LncRNAs on HIV replication
Dr. Smita Kulkarni
2 years
$526,625
20
PRINCIPAL INVESTIGATOR
LENGTH
NEW AWARD TOTAL
NIH/U OF MD University of Maryland Animal Purchase – The Xenotransplantation Program
Dr. Karen Rice
1 year
$147,742
NIH/ SCRIPPS Uncleaved prefusion-optimized trimers on nanoparticles as HIV vaccines
Dr. Robert Lanford
5 year
$1,072,520
NIH Impact of Physical Activity on Striatal Reinnervation in a Nonhuman Primate Model of Parkinson’s Disease
Dr. Marcel Daadi
1 year
$710,357
NIH/U OF MD Rice University of Maryland Animal Purchase VS1582
Dr. Kare Rice
1 year
$95,276
NIH/CELDARA Treatment with CM-SV1 to Sudan virus infected NHP
Dr. Ricardo Carrion
2 years
$339,476
HARRY L. WILLET FOUNDATION/UTHSCSA A non-human primate model of Nontuberculous Mycobacterial (NTM) lung disease
Dr. Suzette Tardif
1 year
$15,266
SAN ANTONIO MEDICAL FOUNDATION Novel Biomarkers and Therapies in Kawasaki Disease
Dr. Jean Patterson
2 years
$130,000
DTRA/DAC Automated Approaches to Analyze and Identify Dual Use Research of Concern for Scientific Publications
Dr. Jean Patterson
1 year
$29,999
BARDA/MAPP BIO — Efficacy Studies for ZMapp CHO
Dr. Ricardo Carrion
2 years
$7,432,494
BARDA/BATTELLE Natural History of Rhesus Macaques Infected with Sudan Ebolavirus Disease
Dr. Ricardo Carrion
2 years
$1,489,964
FOOD & DRUG ADMINISTRATION Bordetella-Free Weanling Baboons
Dr. Karen Rice
1 year
$179,085
FOOD & DRUG ADMINISTRATION/NANOBIO Evaluation of mucosa; vaccination with Nano-Emulsion Adjuvant/Delivery system for Acellular vaccine
Dr. Karen Rice
2 years
$124,709
PRINCIPAL INVESTIGATOR
SPONSOR AND TITLE
LENGTH
NEW AWARD TOTAL
PRINCIPAL INVESTIGATOR
LENGTH
TEXAS MUTUAL Texas Mutual Insurance Company Safety Grant
Dr. Victor Pantusa
1 year
$1,500
SPONSOR AND TITLE
NEW AWARD TOTAL
FOOD & DRUG ADMINISTRATION Bordetella-Free Weanling Baboons
Dr. Karen Rice
1 year
$242,400
DEPARTMENT OF DEFENSE A Novel Strategy for Treating Peripheral Nerve Injury
Dr. Karen Rice
1 year
$234,626
BARDA/BATTELLE Efficacy study of mAb therapeutic against ZEBOV lethal challenge in rhesus macaques
TEXAS BIOMEDICAL FORUM Developing a novel diagnosis test for monitoring treatment success of drug resistant TB in low income areas
Dr. Jordi Torrelles
1 year
$60,000
Dr. Ricardo Carrion
2 years
$1,581,714
TEXAS BIOMEDICAL FORUM Lipid Mediators of Macrophage Metabolism and Immune Responses to Mycobacterium tuberculosis
Dr. Chrissy Leopold Wager
1 year
$59,985
$1,844,948
TEXAS BIOMEDICAL FORUM A novel strategy for Tuberculosis vaccine development
Dr. Varun Dwivedi
1 year
$59,959
TEXAS BIOMEDICAL FORUM Engineering pathogen triggered biomeneralization to enable a new generation of sample-to-answer tests
Dr. Andrew Hayhurst
1 year
$60,000
DOUGLASS FOUNDATION Douglass Foundation Fellowship
Dr. Tucker Piergallini
1 year
$40,800
KRONKOSKY CHARITABLE FOUNDATION BSL3 Equipment Package Donation
Dr. Larry Schlesinger
2 years
$750,000
DOUGLASS FOUNDATION Douglass Foundation Fellowship
Dr. Colwyn Headley
1 year
$41,790
KUMAMOTO UNIVERSITY Development of antiretroviral agents that penetrate the central nervous system and exert potent activity against various HIV-1 v2
Dr. Ruth Ruprecht
1 year
$17,752
UNIVERSITY OF TEXAS HEALTH - SAN ANTONIO External Sale for Hyperglycemia Increases Peripheral Insulin Insensitivity and Alters Pancreatic Development in Baboons
Dr. Karen Rice
1 year
$20,883
BARDA/REGENERON Efficacy study of mAb therapeutic against EBOV lethal challenge in rhesus macaques
2 years
Dr. Ricardo Carrion
Total from Federal Research: $23,904,291 PHILANTHROPIC AND PRIVATE RESEARCH GRANTS SPONSOR AND TITLE
PRINCIPAL INVESTIGATOR
LENGTH
NEW AWARD TOTAL
WILLIAM & ELLA OWENS MEDICAL RESEARCH FOUNDATION Epigenetic editing of neuronal cells as a treatment modality in Alzheimer’s disease
Dr. Melanie Carless
COWLES MEMORIAL TRUST Lipid Mediators of Macrophage Metabolism and Immune Responses to Mycobacterium tuberculosis
Dr. Chrissy Leopold Wager
1 year
$65,766
BILL & MELINDA GATES FOUNDATION/ORHSU Non Surgical Methods of Permanent Contraception
Dr. Karen Rice
1 year
$83,809
1 year
$68,818
Behalf of Genomics
1 year
$28,445
Dr. Suzette Tardif
2 years
$139,022
FOUNDER’S COUNCIL Equipment: Storz Endoscopy Unit
Pat Frost, Veterinary
FOUNDER’S COUNCIL Pippin HT DNA Size Selection System
Shelley Cole, on
PERRY AND RUBY STEVENS CHARITABLE FOUNDATION/UTSA Translantation of Induced Pluripotent stem cell (iPSC) derived dopaminergic neurons to restore function in MPTP treated baboons
Research Resources
2 years
$190,634
Total from Philanthropic and Private Research: $1,689,163 TOTAL OF NEW GRANTS AND CONTRACTS: $27,356,649
21
Texas Biomed Contributions
GIVING IS INFECTIOUS TOO!
P
ainting a scary scenario in his new book The Pandemic Century: One Hundred Years of Panic, Hysteria, and Hubris, author Mark Honigsbaum recaps the emergence of nine infectious diseases including Ebola, HIV, Zika and influenza. These are huge health threats and biomedical mysteries. The book paints an uncertain view of the future. However, what he didn’t account for are researchers like those at Texas Biomedical Research Institute – some of the best scientific minds in the country – mounting a battle to win the war against these pathogens. What do infections have to do with giving? I believe giving is infectious. One of my early mentors called the magic that happens when a contributor “gets it” as catching the “donor bug.” Positively, this “bug” moves from one participant to the next and can accumulate miraculous resources… technologies, facilities and experts at places like Texas Biomed.
Our founder, Tom Slick, Jr., knew about the power of philanthropy and its ability to be contagious. Giving created Texas Biomed. Giving has built our campus. Giving sustains us today. Giving is part of our history and our future. Now is the time to catch the “bug” as Texas Biomed implements a bold, 10-year plan to grow our resources to match the pathogenic challenges of the future and enemies like tuberculosis, MRSA, and pneumonia, to name just a few. Meeting the challenges of the future requires the contributions of each of us today. The generosity of our supporters powers our progress. Join the scientific revolution today. It’s infectious!
Corbett Christie
FOR MORE INFORMATION ABOUT GIVING OPPORTUNITIES, PLEASE CONTACT TEXAS BIOMED VICE PRESIDENT FOR ADVANCEMENT AND PUBLIC RELATIONS CORBETT CHRISTIE AT (210) 258-9870 OR CCHRISTIE@TXBIOMED.ORG, OR VISIT OUR WEBSITE AT WWW.TXBIOMED.ORG AND CLICK ON SUPPORT US.
22
CIRCLES OF GIVING CHAIRMAN’S CIRCLE
Mr. and Mrs. Jack E. Guenther, Jr.
Mr. Lanham Napier and Dr. Dacia Napier
PRESIDENT’S CIRCLE
Mr. and Mrs. Rex Mitchell Amini
Mr. and Mrs. Curtis C. Gunn, Jr.
Dr. Peter W. Nathanielsz
2011 Eric Hill Gift Trust
Dr. and Mrs. C. Collins Anderson
Mr. and Mrs. Frederic Hamilton
Nelson Puett Foundation
Advantage Pain Management
Mr. and Mrs. Robert A. Anderson
Mr. and Mrs. Michael Harper
Mr. and Mrs. John E. Newman, Jr.
Alamo Group
Mrs. Robert R. Archer
H-E-B
Mr. and Mrs. Thomas I. O’Connor III
Mr. and Mrs. John C. Asel
Mr. and Mrs. Edward H. Austin, Jr.
Helen Groves Fund
Mr. and Mrs. Alex H. Oliver
Mr. and Mrs. Brian and Emmy Ballantyne
Mr. and Mrs. Richard N. Azar II
Mr. and Mrs. Ronald J. Herrmann
Mr. Williams Owens
Mr. and Mrs. Edgar A. Basse III
Mr. and Mrs. Sam P. Bell, Jr.
Mrs. George C. Hixon
Phoenix Charitable Foundation
Mr. and Mrs. Craig Boyan
Betty Stieren Kelso Foundation
Mr. and Mrs. George “Timo” Hixon
Mr. and Mrs. Andrew Price
Dr. and Mrs. Ronald K. Calgaard
Bill and Melinda Gates Foundation
Tim and Karen Hixon Foundation
Mr. and Mrs. Nelson H. Puett
Cappy’s
Mr. and Mrs. Craig Boyan
Hixon Properties, Inc.
Mrs. Judy Renick
Mr. Chris Cheever
The Brown Foundation, Inc.
Mr. and Mrs. John R. Hurd
Mr. and Mrs. Barry Coates Roberts
Dr. Robert R. Clemons
Mr. Charles C. Butt
John and Florence Newman Foundation Mr. and Mrs. William A. Johnson
Roger L. and Laura D. Zeller Charitable Foundation
Mr. and Mrs. Justin Cole
Mr. and Mrs. Robert Cavender Mr. and Mrs. Charles E. Cheever, Jr.
Mr. and Mrs. George A. Kampmann, Jr.
Dr. and Mrs. James M.O. Rubin
Mr. and Mrs. John W. Feik
Ms. Phyllis Slick Cowell
Mr. and Mrs. Richard Kardys
The Ruth and Edward Austin Foundation
Mr. H. Rugeley Ferguson, Jr.
Mr. and Mrs. Trey Dawson
Mr. Robert E. Kelso
Mr. and Mrs. Ron Finch
Mr. and Mrs. James L. Donnell, Jr.
Mr. and Mrs. John C. Kerr
Ruth Chapman Cowles & Andrew G. Cowles Memorial Fund
Mrs. James L. Donnell
Mr. and Mrs. William R. Klesse
RWM Foundation
Mr. and Mrs. Thomas Albert Gates, Jr.
Douglass Foundation
Klesse Foundation
San Antonio Area Foundation
Mr. and Mrs. Stephen Goebel
Mr. and Mrs. Alan W. Dreeben
Mr. and Mrs. Cappy Lawton
Mrs. Marie Halff
Elizabeth Huth Coates Charitable Foundation
Ms. Kimberly Spicer Lewis
Mr. Richard T. Schlosberg and Dr. Kathy Schlosberg
Mr. Donald G. Elliott
Mr. Rodney Ray Lewis
Mr. and Mrs. Thomas R. Semmes
Mr. and Mrs. Joe N. Haynes
Mr. and Mrs. Walter Embrey Jr.
Mr. James R. Marmion III
The Honorable and Mrs. John Shields
Ms. Jane Ballantyne Hegeler
Mr. and Mrs. John Feik
Ms. Mary Sue Marmion
Mr. Charles Urschel Slick
Mr. and Mrs. John L. Hendry III
Fletcher Jones Foundation
Mr. and Mrs. L. Lowry Mays
Mrs. Louis Stumberg
Mr. and Mrs. Roger C. Hill, Jr.
Founder’s Council
Mr. and Mrs. Mark P. Mays
Texas Biomedical Forum
Mr. and Mrs. Timo Hixon
G. Harold and Leila Y. Mathers Charitable Foundation
Mays Family Foundation
Mr. and Mrs. Jon Turner
Mr. Thomas Francis Hogan III
Mr. and Mrs. Alex McAlister
Mr. and Mrs. Curtis T. Vaughan III
Mr. and Mrs. Andrew Hunt
Mr. and Mrs. Joseph W. Gorder
Mr. and Mrs. B.J. McCombs
V.H. McNutt Memorial Foundation
Mr. Walter Juliff
Gorman Foundation
McCombs Foundation
Virginia C. Joslin Trust
Mr. and Mrs. Joseph B. Labatt
Mr. and Mrs. James W. Gorman, Jr.
McCrea Foundation
Wave Healthcare, LLC
La Fonda on Main
Mr. and Mrs. William E. Greehey
Mrs. Lewis J. Moorman III
Mr. and Mrs. Edward C. Welsh
Mr. and Mrs. Steven Q. Lee
Mrs. Helen Kleberg Groves
Mr. and Mrs. Lewis J. Moorman IV
Mr. Richard F. Lord (In Memoriam)
Jack and Valerie Guenther Foundation
Ms. Judith N. Morton
William and Ella Owens Medical Research Foundation
Mr. and Mrs. Jack Guenther
Ms. Patricia P. Muir
The Honorable and Mrs. W. Reed Williams
23
Mr. and Mrs. Peter B. Dahlberg
Mr. William Ford
Harris K. & Lois G. Oppenheimer Foundation
Lorene March Partnership CONTINUED ON PAGE 24
CONTINUED FROM PAGE 23
Mr. and Mrs. John Brozovich
Mr. and Mrs. Joe C. McKinney
GOLDEN CIRCLE
Mr. Michael Joseph Lynd, Jr.
Mr. and Mrs. J. Byron Burton III
Mr. and Mrs. Sean McNelis
Mr. and Mrs. Guy Wade Caldwell
Mr. Barclay C. Adams
Mr. and Mrs. Clark R. Mandigo II
McNelis + Associates
Mr. and Mrs. Richard W. Calvert
The Honorable and Mrs. Clyde H. Alexander
Mr. and Mrs. David Mauze
Mrs. Paul E. McSween, Jr.
Mr. and Mrs. Claiborne Ayres Carrington
Mr. and Mrs. Brett Alvheim
Mauze Construction
Mr. and Mrs. John K. Meyer
Ms. Jean Cheever
Mr. and Mrs. Michael Richard Amini
Mr. and Mrs. Matthew Z. Mosser
Mr. and Mrs. Scott Fraser Anderson
MW Construction
Dr. Sarah Trampota Conquest and Mr. Andrew Conquest
Minnie Stevens Piper Foundation Mr. and Mrs. William G. Moll
Mr. and Mrs. Brian Arriaga
Mr. and Mrs. Sergio Montemayor
Ms. Ann Griffith Ash
Mr. and Mrs. James R. W. Daniell
Pape-Dawson Engineers, Inc.
Mrs. Isabelle Badouh
Mr. and Mrs. Christopher H. Dewar
Mr. and Mrs. Gardner Peavy
Mr. and Mrs. Jeff P. Bailey
DuWest Realty
Mr. and Mrs. Scott Petty, Jr.
Mr. and Mrs. William J. Baine
Mr. Thomas H. Edson
Project Control of Texas
Mr. and Mrs. James D. Ellis
R.L. Worth Family, L.P.
Ferguson Enterprises, Inc.
RSM US LLP
Mr. Robert H. Finney and Dr. Nancy A. Finney
Dr. and Mrs. Frank C. Sammis III
Mrs. Charles E. Foster
Mr. and Mrs. William Scanlan, Jr.
Mr. and Mrs. Aubra L. Franklin
Silver Eagle Distributors
Ms. Lynn Tidwell Neff Nordan Trust Mr. Charles G. Northrup Mrs. Claire Oppenheimer O’Malley Mr. and Mrs. George Parker, Jr. Mr. and Mrs. Allan G. Paterson Ms. Roxana McCallister Richardson Rugeley Ferguson Foundation Mr. and Mrs. James B. Smith Mr. and Mrs. Jack J. Spector Mr. and Mrs. S. Van Stewart Dr. Joanne Turner Uhl, Fitzsimons, Kewett & Burton, PLLC Ms. Ann Brennand Watson Mr. and Mrs. Warren S. Wilkinson, Jr. Mr. and Mrs. James P. Zachry Mr. and Mrs. John B. Zachry
BENEFACTOR’S CIRCLE Mr. and Mrs. Aaron Asel
Daniel J. Sullivan Family Charitable Foundation
Frost Bank
Mr. and Mrs. Bruce A. Smith
Mr. and Mrs. James L. Glover
Mr. and Mrs. Joseph Stewart Bakke Mr. and Mrs. Stephen P. Ballantyne Mr. and Mrs. A.L. Ballard Mr. and Mrs. James Hunter Barrow Mr. Bruce B. Barshop Mrs. Sam Barshop Mr. and Mrs. Lee M. Bass Mr. and Mrs. J. Dan Bates
Mr. and Mrs. James B. Smith, Jr.
Mr. and Mrs. Jim Baxter
SpawGlass
BB&T
Dr. and Mrs. Norton A. Stuart III
Mr. and Mrs. Brian Beem
Mrs. Daniel J. Sullivan IV (In Memoriam)
Mr. and Mrs. Will Alston Beinhorn
The Tobin Endowment
Mr. and Mrs. Jonathon Beitz
Mr. and Mrs. John R. Hurd, Jr.
TransPecos Banks
Mr. and Mrs. Michael D. Beldon
Jackson Walker, LLP
Mrs. Marion Dewar Bell
Joeris General Contractors
Mr. Dale W. Tremblay and Dr. Sandra Tremblay
Mr. and Mrs. Michael L. Benedum
Mr. and Mrs. James B. Griffin Guido Construction Mr. and Mrs. Harry Halff Mr. and Mrs. Reagan Houston IV Mr. and Mrs. Mark S. Howard
Mr. and Mrs. Matthew M. Bell
Joseph and Madelon Harrison Family Advised Fund
Mr. and Mrs. Jason Westmoreland
Asel and Associates
Dr. and Mrs. Gary Koehl
Mr. and Mrs. Edward E. Whitacre, Jr.
Mr. and Mrs. Barry G. Benton
Mr. and Mrs. Geary Atherton
Mr. and Mrs. Bob Kolitz
Mr. and Mrs. Jack Williams III
Mr. and Mrs. Ryan Berg
Bank of America
Lt. Gen. Frank (In Memoriam) and Mrs. Marilyn Ledford
Mr. and Mrs. James M. Wolff
Mr. and Mrs. Richard Bergmann
Bank of San Antonio
Mr. and Mrs. Clint Worth
Mr. Jeffrey H. Berler
Mr. and Mrs. Brian Beem
Mr. Samuel E. Maclin
Ms. Margery L. Block
Mr. and Mrs. Robert L. Worth, Jr.
Ms. Ann Marmion
Broadway Bank
Marsh Wortham
Mrs. Walter F. Brown
Matera Paper Company
Brown and Ortiz, P.C.
Mr. and Mrs. Robert S. McClane
Advantage Pain Management
Worth and Associates Mr. and Mrs. Keith Zars
Mrs. Lawrence A. Bertetti Mr. and Mrs. Albert M. Biedenharn III Mr. and Mrs. Tim Blonkvist Mr. and Mrs. Cooper N. Boddy Mr. and Mrs. Greg Bolner
24
Congressman and Mrs. Henry Bonilla
Mr. and Mrs. Jeffrey de Rojas
Mr. and Mrs. Robert Gurwitz
JP Morgan
Mr. and Mrs. Robert L. Bowers
Mr. and Mrs. Michael Dewar
Mr. and Mrs. Ricardo Guzman
Mrs. George A. Kampmann
Miss Marrs McLean Bowman
Mr. and Mrs. Robert L. Dewar
Mr. and Mrs. Mark Hanrahan
Mr. and Mrs. Patrick J. Kennedy
Mr. and Mrs. McLean Bowman
Mr. and Mrs. Kenneth Dorbandt
Mr. and Mrs. William E. Harrison, Jr.
Mr. and Mrs. Patrick J. Kennedy, Jr.
Mr. Paul Bracher
Mr. and Mrs. Taylor Dorris
Ms. Mary Austin Hart
Mr. and Mrs. Evan Ketabchi
Mr. Jonathan Bradley
Mr. and Mrs. William E. Dreyer
Mr. and Mrs. Warren B. Hart II
Mrs. Sue Killam
Dr. and Mrs. Warren B. Branch
Mr. and Mrs. Donald Y. Duffin
Mr. and Mrs. Houston Harte
Mr. and Mrs. Creston A. King III
Mr. and Mrs. James C. Browning
Mrs. Betty Ann Ebrom
Mr. H. Burt Hause
Mr. and Mrs. Robert A. Kiolbassa
Mr. and Mrs. Harry H. Brusenhan
Mr. and Mrs. Jeff Edwards
Mr. and Mrs. Albert F. Hausser
Kittie Nelson Ferguson Foundation
Mr. and Mrs. James H. Bryan, Jr.
Mr. and Mrs. Michael Ellis
Mr. and Mrs. James L. Hayne
Mr. Shaj and Dr. Avina Kolareth
Mr. and Mrs. J. Bruce Bugg, Jr.
Eugenia and Lawrence A. Bertetti Foundation
Mrs. Frances J. Hearn
Mr. Bart Koontz
Mrs. George V. Burkholder
Dr. and Mrs. John A. Evans
Mr. and Mrs. Jeffrey E. Heinke
Mr. and Mrs. Edward K. Kopplow
Mr. and Mrs. Stephen W. Butt
Mr. and Mrs. Richard W. Evans, Jr.
Mr. and Mrs. Roger Hemminghaus
Mr. and Mrs. John C. Korbell
Mrs. Walter J. Buzzini III
Mr. and Mrs. John Feik, Jr.
Mr. and Mrs. Stuart Carl Hendry
Mr. and Mrs. Gregory W. Kowalski
Mr. and Mrs. A.H. Cadwallader IV
Mr. Robert H. Finney and Dr. Nancy A. Finney
Mr. Jonathan Hess
Ms. Rosemary Kowalski
Mr. and Mrs. Presnall Cage
Mr. and Mrs. Eric Fisher
Ms. Henrietta P.C. Hildebrand
Mr. Michael L. Kreager
Dean Charles E. Cantu
Mr. and Mrs. Hugh Fitzsimons, Jr.
Mr. and Mrs. Russell Hoermann
Dr. and Mrs. Ariel Kruger
Dr. and Mrs. Carlos Cardenas
Mr. and Mrs. W.W. Flannery, Jr.
Mr. and Mrs. Benjamin B. Holliday
Mr. and Mrs. William Jeffrey Kuhn
Dr. Melanie Carless and Dr. Mark Kos
Mr. Charles A. Forster
Mr. and Mrs. Charles R. Hollimon
Dr. and Mrs. Robert Lanford
Mr. and Mrs. John Brozovich Cardno
Mr. and Mrs. Tom Frost, Jr.
Dr. Peter W. Hollimon and Dr. Mary H. Arno
Mr. and Mrs. Clint Lawson
Mrs. Cassandra C. Carr
Mr. and Mrs. Mark Garcia
Mr. and Mrs. Al Honigblum
Mr. Trevor Lawton and Ms. Amy Stinson
Mr. and Mrs. William Carrington
Mr. and Mrs. David Gard
Mr. and Mrs. Michael Howard
Mr. and Mrs. Milton B. Lee
Mr. and Mrs. James M. Caruth
Mr. and Mrs. George A. Geis
Mr. and Mrs. Ladd J. Howell
Mr. and Mrs. Byron L. LeFlore, Jr.
Mrs. James M. Cavender III
Mr. and Mrs. Evan Gerald
Mr. and Mrs. Dan Allen Hughes, Jr.
Mr. and Mrs. Ralph Lehr, Jr.
Mr. and Mrs. Pedro Cerisola
Mr. Lukin T. Gilliland, Jr.
Mr. Christian Hummel
Mr. and Mrs. Thomas Robert Leslie IV
Mr. and Mrs. B. Corbett Christie
Dr. and Mrs. Joseph W. Goldzieher
Mr. and Mrs. Andrew Hunt
Mrs. John R. Less
Mrs. Malcolm H. Cohen
Dr. and Mrs. William Gordon
Ms. Sara Smith Hurd
Mr. and Mrs. Steve C. Lewis
Mrs. Richard T. Coiner III
Mr. and Mrs. Chase Gorman
Jackson Walker, LLP
Mr. and Mrs. Cinco Light
Mr. and Mrs. Norborne P. Cole, Jr.
Mr. and Mrs. James B. Gouger
Mr. and Mrs. Kenneth M. Jastrow II
Ms. Joyce Lindler
Mrs. George J. Condos
Mr. and Mrs. John Paul Gould
Mr. and Mrs. Jeremy Jessop
Ms. Judith Lindquist
Mrs. John Crichton
Dr. and Mrs. Joseph Grant
Mr. and Mrs. Taylor Little
Mr. Michael Cruz and Mrs. Lisa Cruz
Mr. and Mrs. Claiborne B. Gregory, Jr.
Jody and Sheila Grant Fund of Communities Foundation
Mr. and Mrs. Paul T. Curl
Mr. and Mrs. James B. Griffin
Mr. and Mrs. Henry Clay Johnson
Mr. and Mrs. Cullen Rogers Looney
Mr. and Mrs. James R.W. Daniell
Mr. and Mrs. Brandon E. Grossman
Dr. Johnny Clay Johnson
Mr. and Mrs. Porter Loring, III
Mr. Keith A. Davis
Mr. and Mrs. Craig J. Guaransuay
Mr. and Mrs. Tony C. Johnson
Mr. and Mrs. Howard H. Lutz
Mr. Taylor Dawson
Dr. and Mrs. Kennon Guglielmo
Mr. and Mrs. Ansley E. Johnston
Mr. and Mrs. Mike MacNaughton
Mr. and Mrs. Jeffrey de Rojas
Mr. and Mrs. Cosmo M. Guido
Mr. and Mrs. J. Bradley Jones
Mrs. Leroy G. Denman, Jr.
Mr. and Mrs. Thomas L. Guido
Mrs. Joe Warren Jones
Mr. and Mrs. Glenn MacTaggart CONTINUED ON PAGE 26
25
Mr. and Mrs. David G. Lloyd, Jr.
CONTINUED FROM PAGE 25
Ms. Evangeline Myers
Mr. and Mrs. David Schlagel
Mr. Kenneth Edward Train
Mr. and Mrs. Gregory Mann
Mr. and Mrs. Robert L. Myers
Dr. and Mrs. Larry S. Schlesinger
Mr. and Mrs. Richard C. Traylor
Mr. and Mrs. Bob Marbut
Mr. and Mrs. Scott Nathan
Mr. and Mrs. J. Thomas Schmidt
Mr. Kenneth P. Trevett
Ms. Margo Spitz Marbut
Mr. and Mrs. John Liston Nau III
Mrs. Robert L. Schupbach
Dr. and Mrs. George J. Vassar
Mr. and Mrs. Madison C. Marceau
Mr. and Mrs. Eric Neuner P.E.
Mr. and Mrs. Harry F. Schwethelm, Jr.
Mr. and Mrs. Chris Marco
Mr. and Mrs. David F. Nicolson III
Mr. and Mrs. Stuart Seal
Marsh Wortham
Dr. and Mrs. Aris Nikas
Mrs. H. Kyle Seale
Mr. and Mrs. Charles G. Martens
Mr. and Mrs. John A. Oberman
Mr. and Mrs. Donnie Seay
Mr. and Mrs. Keith O’Connell
Mr. and Mrs. Peter C. Selig
Mr. and Mrs. Lawrence O’Connor
Dr. and Mrs. Antonio Serna, IV
Mr. and Mrs. W. Lawrence Walker III
Mr. Robert Ochoa
Mr. and Mrs. Robert Eric Shaw
Mr. and Mrs. Neill Bailey Walsdorf
Mr. and Mrs. Steven M. Ogle
Mr. and Mrs. Chip Shirley
Mr. and Mrs. Mark E. Watson, Jr.
Mrs. Clara Shovlin
Mr. and Mrs. Mark E. Watson III
Mr. and Mrs. Pete Sitterle
Mr. and Mrs. Conrad Weaver
Mr. Charles U. Slick, Jr.
Mrs. Don E. Weber
Mr. Tom B. Slick, Jr.
Mr. and Mrs. Dan G. Webster III
Mr. Paul Martin Mr. and Mrs. Madison Mauze Mr. and Mrs. Jess Mayfield Mr. and Mrs. Chance Mazurek Mr. and Mrs. Alexander S. McAllister Mr. and Mrs. Walter W. McAllister III Mr. and Mrs. David McArthur Mr. David and Mrs. Jeannie Hegeler McArthur Mr. and Mrs. Norris Robert McClane Mr. and Mrs. Don B. McDonald, Jr. Ms. K. Heather McFarlin Mr. and Mrs. Elkin McGaughy Mrs. Anne O. McNeel Mrs. Jo Lynne Meador Dr. and Mrs. Gilbert R. Meadows
Mrs. Frederic J. Oppenheimer Mrs. Susan Oppenheimer Mr. and Mrs. William B. Osborn III Mr. and Mrs. John Carroll Park
Dr. and Mrs. Lon S. Smith
Mrs. Harry J. Parker
Mr. and Mrs. J. Dudley Snyder
Mrs. William A. Parker
Mrs. Marshall T. Steves, Sr.
Dr. and Mrs. Mahendra Patel
Mr. and Mrs. Sam Bell Steves III
Mr. and Mrs. Henry B. Paup
Mr. and Mrs. Drew Stewart
Mrs. Tom E. Pawel
Mrs. John Stewart
Dr. and Mrs. Daniel C. Peavy Mr. and Mrs. Gardner Peavy Mr. and Mrs. Christopher Petty
Mr. and Mrs. Ben F. Vaughan IV Mr. and Mrs. Michael N. Venson Mr. and Mrs. Jack Vexler Mr. and Mrs. W. Lawrence Walker, Jr.
Mr. and Mrs. Alex P. Weekes Mr. and Mrs. Heath Wenrich Ms. Kittie West Whataburger Dr. Alexis Wiesenthal
Mr. and Mrs. Julian C. Stewart
Ms. Francie Whittenburg
Mr. and Mrs. Leland M. Stone
Mr. and Mrs. Chris Wilde
Mr. and Mrs. Matthew Strange
Mr. and Mrs. James Y. Williams
Mrs. Thomas D. Stribling
Mr. and Mrs. Roger Winter
Mr. and Mrs. L. Herbert Stumberg, Jr.
Mr. and Mrs. George J. Wommack
Mr. Eduardo Meza
Mr. and Mrs. John A. Peveto, Jr.
Mr. Fred W. Middleton
Mr. and Mrs. Philip J. Pfeiffer
Milam Real Estate
Mr. and Mrs. Alistair F. Philip
Mr. and Mrs. Balous T. Miller
Mr. and Mrs. William “Dub” Sutherland
Mr. Ben Pressentin
Mr. and Mrs. John G. Wright
Mr. and Mrs. Joe Miller
Mr. and Mrs. William Sutherland
Mr. and Mrs. William H. Quirk IV
Mrs. Leon C. Wulfe, Jr.
Dr. and Mrs. Joseph P. Miller
Mr. and Mrs. Timothy L. Swan
Mr. and Mrs. Lane Riggs
Mission Title
Mr. and Mrs. Stephen Lee Swanson
Dr. and Mrs. Mark C. Rittenhouse
Mr. Patrick H. Swearingen, Jr.
Mr. and Mrs. Stuart D. Moiles
Mr. and Mrs. Paul Rohlfs
Dr. and Mrs. Casey Taber
Mr. and Mrs. Michael L. Molak
Mr. and Mrs. Paul A. Rohlfs, Jr.
Mr. Charles W. Tate
Mr. and Mrs. Edward D. Moore
Mr. and Mrs. Forrest Runnels, Jr.
Dr. and Mrs. Alvin Thaggard III
Mr. and Mrs. Keith Zars
Mr. and Mrs. John Moorman
Mrs. Ruth Bowman Russell
Mr. and Mrs. John C. Thomas
Mr. and Mrs. Joshua Zeller
Mrs. Jeffrey M. Morehouse
RVK Architects
Mr. Ron Thompson
Mr. and Mrs. Thad W. Ziegler
Mr. and Mrs. Randall Morris
Dr. and Mrs. Frank C. Sammis III
Dr. and Mrs. Brad S. Tolin
Mrs. Marion C. Zoch
26
Mr. Mike Yantis Yantis Company Mr. and Mrs. Peter Zacher Mr. and Mrs. H. Bartell Zachry, Jr.
TEXAS BIOMED FORUM
I
n 1970, Dottie Block, Tena Gorman and Ruth Eilene Sullivan had a vision to create an organization of dedicated and like-minded women to support Texas Biomed. The cornerstone of this organization was built on ideals implemented by our founders: volunteerism, community relations and fundraising — standards of success that the Forum upholds enthusiastically today. Our unofficial mantra this year has been, “Women Supporting Science and Each Other” and what a year we have had!
THE WORK OF THE FORUM IS VITAL TO FUND THOSE IDEAS IN THE INCUBATOR STAGE SO THAT TEXAS BIOMED SCIENTISTS CAN CONTINUE DOWN THE PATH OF SCIENTIFIC DISCOVERY.
Community relations took on many dynamics this year, with our Lecture Luncheons, Cocktails with Scientists Roundtable, Cheers to Chairity, and our student outreach efforts via our student tours program and Science Education Awards. We began this year with our Fall Lecture Luncheon, a hallmark of our outreach efforts. Dr. Joanne Turner, Texas Biomedical Research Institute’s Vice President for Research and a previous Forum Grant recipient, discussed her career, professional goals and the role of women in science and executive leadership positions. This was followed by our Cocktails with Scientists Roundtable program which allowed our members and guests to interact with multiple scientists in one evening. In the fall, we hosted our Past Presidents at a luncheon generously sponsored by Texas Biomed at The Argyle. We honored the legacy of the outstanding women who have guided this organization for more than 40 years and celebrated the strong future that lies ahead for the Forum. We are incredibly grateful for the ongoing support from our esteemed group of Past Presidents. They have and continue to shape our organization in many ways.
Over the course of the Forum’s storied history, the organization has raised over $3 million for Texas Biomed pilot studies via our Forum Grants program. These seed grants, the Forum’s initial investment in promising work, has returned $83 million in additional funding for Texas Biomed. We often say that what starts at the Forum plants the seed to change the world. It is one of the most rewarding aspects of serving the Forum, to see Texas Biomed scientists achieve great success after receiving one of our grants.
In February, the Forum hosted our second Cheers to Chairity event in which 12 talented local designers reimagined dining chairs generously donated by The Argyle after the recent renovation projects. This beautiful event was another successful Forum fundraiser. We welcomed spring with our second lecture luncheon of the year where Texas Biomed President and CEO, Larry Schlesinger, M.D. discussed, “You, Your Loved Ones and Infection: The Impact of Infection on Our Daily Lives.” At this event, we also recognized the winners of our 25th annual Science Education Awards. This beloved program was founded by former Forum Trustee Valerie Guenther and former Forum President Jerilyn Blanchard. Our ongoing partnership with Mrs. Guenther and the V.H. McNutt Memorial Foundation allows the Forum to recognize outstanding local high school science teachers who are developing innovative, hands-on science curriculum. This year’s winners presented outstanding projects that spanned several science genres and
Thanks to our Board of Trustees, Advisors, Honorary Advisors, and general membership, we are able to impact the work of Texas Biomed in a variety of ways. Forum membership dues help fund our general needs such as operating expenses, administrative costs and most importantly, our Science Education Awards Program for teachers. Membership in the Forum is open to all women 21 years of age and over interested in promoting the work of the Forum and Texas Biomed. Our membership campaign kicks offs every summer and membership can be initiated or renewed online at any time.
27
represented Saint Mary’s Hall, Cornerstone Christian School and Earl Warren High School.
(l to r) Denise Mosser, Chair of the 2018 Gala, presented a check for the 2018 Gala proceeds to Dr. Larry Schlesinger, Texas Biomed President/ CEO alongside Nicole McClane, Gala Co-chair and Courtney Percy, 2017-2018 President of the Forum.
Throughout the year, Forum Trustees also serve as ambassadors for local high school science classes touring the Texas Biomed campus. This year’s participants included students from Saint Mary’s Hall, Southside High School, Lee High School’s STEM program, La Vernia High School and Natalia High School. The hallmark of the Forum year is always our annual Gala, held the first Saturday of May. One of the most highly anticipated social events of the year, each Gala is thematically unique and crafted with great care by our outstanding Gala team. This talented group of volunteers executed another phenomenally successful event with, “The Night They Invented Champagne.” Funds raised at The Gala and as part of our Forum Grants efforts are utilized to fund pilot studies by Texas Biomed scientists to achieve results needed to apply for larger grants funded by national and government agencies.
The Forum awarded $251,294 in grants to scientists at Texas Biomedical Research Institute
to assist in developing preliminary data that will enable these scientists to secure future funding for novel projects. The following projects were funded in 2018.
SCIENTISTS Andrew Hayhurst, Ph.D. Dr. Hayhurst’s project is a proof-of-concept study to evaluate the potential of a novel process for the facile detection of pathogens in the field. Using Marburg virus as our model pathogen, his team will test the feasibility and sensitivity of the system.
You may have noticed our newsletters while visiting The Argyle. These are printed three times a year and are mailed to members and made available digitally on our website. The Forum is also active on social media, including Facebook, Instagram and LinkedIn. These combined efforts allow the Forum to share important information about the groundbreaking work at Texas Biomed with our membership as well as an audience of potential supporters and enthusiastic volunteers.
Jordi Torrelles, Ph.D. Dr. Torrelles is working to develop and test the performance of a 2nd generation TB Color Plate test with the ultimate goal of developing and implementing a faster (14 vs. 56-84 days), fieldbased, easy-to-use and inexpensive drug susceptibility testing (DST) for drug-resistant TB in high TB index rate regions. This will allow faster detection, cost reductions, and thus, significantly aid in preventing transmission of drug-resistant TB in humans.
The Forum greatly values what a treasure Texas Biomed is, and we are honored to work to educate the community about the importance of the scientific work being accomplished on campus. There is so much truth in the statement that what starts at the Forum plants the seed to change the world. The work of the Forum is vital to fund those ideas in the incubator stage so that Texas Biomed scientists can continue down the path of scientific discovery.
STAFF SCIENTISTS
Thanks to our past leadership, the Forum continues to be an organization of distinction. Personally, I am grateful to all those who have invested their time and resources in this outstanding organization. It has been both a tremendous honor and a great privilege to serve as this year’s Forum President. I look forward to cheering the Forum on as the organization continues to grow and accomplish great things. With gratitude and in service,
Jody Lutz, 2018 Forum President
28
Varun Dwivedi, Ph.D. Dr. Dwivedi proposes a strategy of host derived IL-10 modulation, strictly at the time of vaccination for generating a qualitatively different set of T cells resulting in sustained long-term protection against M.tb infection in mice.
POST-DOCTORAL SCIENTISTS Chrissy Leopold Wager, Ph.D. Macrophages are host immune cells that are critical for controlling TB. Dr. Leopold-Wager’s project focuses on the role of lipid signaling molecules known as eicosanoids on macrophage responses. We are investigating the kinetic release of eicosanoids in TB infected human macrophages and will determine the effects of eicosanoids on macrophage activation and metabolism as well as TB pathogenesis. This project will provide insight into pathways that can be targeted for novel approaches to host-directed therapy for TB.
FOUNDER’S COUNCIL
T
he Founder’s Council is a dynamic group of professionals and young leaders between the ages of 25 and 46 founded in 1988 to honor the memory of Tom Slick and to promote Texas Biomedical Research Institute.
THE FOUNDER’S COUNCIL EXISTS TO EDUCATE ITS MEMBERS ABOUT THE LIFE-CHANGING RESEARCH CONDUCTED EVERY DAY AT TEXAS BIOMED.
Historically, the Founder’s Council has distributed 10 to 15 equipment grants per year ranging from $2,500 to $7,500 each. In 2018, the Founder’s Council board of directors voted in favor of distributing fewer yet higher-value grants. We are very proud to report that our grants — which now average $40,000 each — are even more impactful to Texas Biomed.
The mission of the Founder’s Council is to cultivate interest in Texas Biomed among young leaders in the greater San Antonio region who show potential for lifelong support of Texas Biomed. The Founder’s Council has approximately 400 diverse members from all walks of life whose annual contributions and sponsorships help fund equipment grants for Texas Biomed scientists. Texas Biomed had an exciting 2018 as Dr. Larry Schlesinger settled into his new position as President and CEO.
As President of the Founder’s Council, I was honored to be an ex officio member of the Texas Biomed Board of Trustees. In Board meetings, I had a unique opportunity to witness the leadership, vision, and confidence that Larry brings to Texas Biomed. In June 2018, he received Board approval to undertake an aggressive strategic plan to completely rebuild the Texas Biomed campus, increase staff and funding, and most importantly, help Texas Biomed become known throughout the world. Larry has earned the respect of his staff, our board of directors and City leaders. I would like to thank him personally for his guidance and support throughout the year. Because we know that behind every successful man is a supportive woman, I also would like to thank the First Lady of Texas Biomed, Larry’s wife, Judy.
29
The Founder’s Council delivered three fantastic Lecture Luncheons throughout the year at which Texas Biomed scientists Dr. Marie-Claire Gauduin, Dr. Ian Cheeseman and Dr. Jordi Torrelles shared their cutting-edge research with our membership and prospective new members. In March of last year, members enjoyed the premiere event, Dining and Discourse, where scientists joined a table of guests in an intimate setting for dinner at The Argyle, allowing for candid conversations around their areas of expertise. In May, we and our prospective members were fortunate to enjoy an informative VIP tour of the Texas Biomed campus, and in October, we hosted a new member event at La Fonda on Main. We especially thank our event sponsors who underwrite 100 percent of our event costs, allowing the Founder’s Council to contribute more substantially to our equipment grants. We concluded 2018 with a holiday party at Dacia and Lanham Napier’s home and were honored to present Dr. Joanne Turner, Vice President for Research for Texas Biomed, with equipment grant awards totaling more than $97,000. The Founder’s Council exists to educate its members about life-changing research conducted every day at Texas Biomed, to empower our members, then to educate their communities and colleagues about the Institute’s efforts and strides. It is our sincerest hope, that once informed, these community leaders also will financially support Texas Biomed so that it may continue for generations its noble and necessary science. This year played a vital role in helping Texas Biomed make a global impact, and we are honored to carry on this distinguished tradition. At the service of Texas Biomed, Trey Dawson, 2018 President, Founder’s Council
2018 FOUNDER’S COUNCIL EXPLORERS
ADVENTURERS
Mr. and Mrs. Brett Alvheim Mr. and Mrs. Aaron Asel Mr. and Mrs. Jeff P. Bailey Mr. and Mrs. Jonathon Beitz Mr. and Mrs. Matthew M. Bell Mr. and Mrs. Ryan Berg Mr. J. Craig Browning, Jr. Mr. and Mrs. John Brozovich Mr. and Mrs. Trey Dawson Mr. and Mrs. Jeffrey de Rojas Mr. and Mrs. John W. Feik, Jr. Mr. Robert H. Finney and Dr. Nancy A. Finney Mr. and Mrs. Craig J. Garansuay Mr. and Mrs. David Gard Mr. and Mrs. Evan and Renee Gerald Mr. Jonathan Hess Mr. and Mrs. Benjamin B. Holliday Mr. and Mrs. Charles R. Hollimon Mr. and Mrs. Andrew Hunt Mr. and Mrs. Tony C. Johnson Mr. and Mrs. Byron L. LeFlore, Jr. Mr. and Mrs. David G. Lloyd, Jr. Mr. and Mrs. Taylor Little Mr. and Mrs. Madison C. Marceau Mr. and Mrs. Charles G. Martens Mr. and Mrs. David Mauze Mr. and Mrs. Madison Mauze Mr. and Mrs. Chance Mazurek Mr. and Mrs. Alexander S. McAllister Mr. and Mrs. David McArthur Mr. and Mrs. Joe Miller Ms. Evangeline Myers Mr. and Mrs. Scott Nathan Mr. Robert Ochoa Mr. and Mrs. Gardner Peavy Mr. and Mrs. Andrew B. Price Dr. and Mrs. Antonio Serna IV Mr. Trevor Lawton and Ms. Amy Stinson Mr. and Mrs. Conrad “Rad” Weaver Dr. Alexis Wiesenthal Mr. and Mrs. George J. Wommack
Mr. and Mrs. Scott Fraser Anderson Mr. and Mrs. Brian and Emmy Ballantyne Mr. and Mrs. R. Bruce Walker Mr and Mrs. Charles Conner Mr. and Mrs. Alex Childers Mr. Mark De Hoyos Mr. and Mrs. Albert Dickson Mr. and Mrs. Kenneth Dorbandt Mr. and Mrs. Marty Dusek Mr. and Mrs. Andrew T. Friedman Mr. and Mrs. Casey Fry Mr. Sean Galligan Mr. and Mrs. Lane Golden Mr. and Mrs. James B. Griffin Mr. Carlo Gutierrez Mr. and Mrs. William Kothmann Mr. and Mrs. Daniel Lasater Mr. Andrew J. Lewis IV Mr. and Ms. Will Newburn Mr. and Mrs. Kyle Palmer Mr. Krishna Reddy Ms. Katie Reynolds Mr. and Mrs. J.B. Richter Mr. and Mrs. Paul A. Rohlfs, Jr. Mr. and Mrs. Robert Shaw Mr. and Mrs. Paxton Jordan Smith Mr. and Mrs. Mellick Sykes, Jr. Mr. and Mrs. Robert Turnbull Mr. and Mrs. Marc Whyte Mr. and Mrs. Scott Wiggans Mr. Steven Frederick Willson
MEMBERS Ms. Selena Aleman Mr. and Mrs. Landon Anderson Mr. Suhail Arastu Mr. and Mrs. Scott Archer Mr. and Mrs. Joe Ashby Mr. and Mrs. Matthew Badders Mr. and Mrs. Tom Bagby III Mr. John W. Ballantyne
30
Mr. and Mrs. Edward Bartolomei Mr. and Mrs. Brad Beldon Mr. and Mrs. Joshua Berg Mr. and Mrs. Greg Bolner Mr. and Mrs. Forrest Bowman Mr. Kyle Braaten Mr. and Mrs. William A. Brooks Mr. Jeffrey Brouillard Ms. Cheryl Burkhardt Mr. and Mrs. Aldes H. Cadwallader V Mr. and Mrs. Andrew and Sara Cardwell Dr. and Mrs. McCurdy Cardwell Mr. Brandon Carpenter Mr. and Mrs. Bradley Carson Mr. Paul B. Carter Mr. and Mrs. Stuart Carter Mr. Robert M. Cavender Jr. Mr. and Mrs. James Chandler Mr. and Mrs. Brandon Clementson Mr. Andrew R. Craig Ms. Kalyn Davidson Dr. Susie DeKoch Mr. and Mrs. Jay Dewald Ms. Nancy Hanks Dewar Mr. and Mrs. Taylor Dorris Mr. and Mrs. Robert A. Dullnig Mr. Will Fawcett Mr. and Mrs. Johnny Fitzsimons Mr. and Mrs. Chase Gorman Mr. and Mrs. Ryan Griffin Mr. and Mrs. Roger C. Hill III Mr. and Mrs. Charles M. Hornberger Mr. and Mrs. David Hornberger Mr. and Mrs. Anson and Meredith Howard Mr. and Mrs. Joel Hoyt Mr. and Mrs. Robert Jones Mr. and Mrs. Phil Kandera Mr. and Mrs. Clifton Karam Mr. and Mrs. Matthew Koehler Mr. and Mrs. Parker LaBarge Dr. and Mrs. Brian Langford Mr. and Mrs. Colby Lewis Mr. and Mrs. Alcide M. Longoria Mr. and Mrs. Peter Mako
Mr. and Mrs. Chance Mazurek Mr. and Mrs. William L. McCamish Mr. Robert T. McCullough Mr. and Mrs. R.W. McDonald Mr. and Mrs. Brad McMurray Ms. Catriona L. Morrison Mr. and Mrs. Brian O’Gorman Mr. and Mrs. Ross and Whitney Ormond Mr. and Mrs. Kyle Palmer Mr & Mrs Tres Peacock Mr. Benjamin Pilgrimww Mr. and Mrs. Jack Marshall Porterfield Judge Carla Martinez Riedl Ms. Kylee Robinson Mr. and Mrs. Patrick Rouse Mr. and Mrs. Conner Ryan Mr. and Mrs. Wes Sharples Mr. Jonathon R. Schneider Mr. and Mrs. Bryan Schones Mr. and Mrs. Robert Webb Sellers, Jr. Ms. Abigail Shaver Mr. Ty Hunter Sheehan Mr. and Mrs. Alan Spalten Mr. and Ms. Blake Stouffer Ms. Delaney Tholen Mr. and Mrs. Frederick Thomson IV Mr. Hunter Thunell Mr. and Mrs. Matt Toohey Mrs. Paula Waggoner-Aguilar Drs. Christopher and Kathryn Walker Mr. and Mrs. Bart Waters Mr. and Mrs. Robert Watson, Jr. Mr. Barkley Wedemeyer Mr. and Mrs. William Daniel Westmoreland Dr. Alison Wiesenthal Mr. and Mrs. Brandon Williams Mr. and Mrs. James Y. Williams Mr. Ben Wilson Mr. Cole Wollak and Ms. Aysun Bal Mr. and Mrs. Elgin Wong Mr. and Mrs. John H. Wright IV Mr. and Mrs. David S. Zachry Mr. and Mrs. Will F. Ziegler
CORPORATIONS/SPONSORS Advantage Pain Management Mr. Andrew Conquest Dr. Sarah Trampota Conquest Asel & Associates, PLLC Mr. Aaron Asel Mr. John Asel
Milam Real Estate Capital, LLC Mrs. Burkley Fitzsimons Mr. Vincent Dawson MW Construction Mr. Maurice L. Williams Nelson Puett Foundation Mrs. Callie Puett Price
BB&T Ms. Stephanie Dick Mr. Ben Pressentin
Pape-Dawson Engineers, Inc. Mr. Trey Dawson Mr. Taylor Dawson
Broadway Bank Wealth Management Mr. Robert Ochoa Mrs. Elizabeth Hetrick
Project Control of Texas, Inc. Mr. Andrew Hunt Mr. John Duhrig
Broussard Group Mr. and Mrs. Bret E. Brossard
RSM US LLP Ms. Josie Behrend Ms. Vicky Martin
Brown & Ortiz, P.C. Mr. James B. Griffin
RVK Architects Mr. Heath Wenrich Mr. Jason Puchot
Cardno Structural Engineers Ms. Lauren Setterbo Mr. David Carter
Silver Eagle Distributors, L.P. Ms. Katie Reynolds Mr. Mark De Hoyos
DuWest Realty Mr. Evan Ketabchi
SpawGlass Mr. Jason Smith Ms. Stephanie Dixon
Frost Mrs. Mallony Ahl Mrs. Mary Stephanie Looke
The Bank of San Antonio Mr. Jordan Booth Ms. Kacy Smith
Guido Construction Mr. Cosmo F. Guido Mr. Ted Zimmerhanzel IBC Bank Mrs. Jennifer Martinez MuenChow Mr. Bernando De la Garza Jackson Walker, LLP Ms. Lauren Ciminello Ms. Alexine Freidman
The Tobin Endowment Mr. J. Bruce Bugg, Jr. Transpecos Banks Mr. George Mussleman Mr. Matthew McLaughlin Whataburger Mrs. Linda Benavides Ms. Kim Harle
Joeris General Contractors Mr. Gary Joeris Mr. Jeff Bryant
Worth & Associates Mr. Robert Clinton Worth
JPMorgan Chase Ms. Michele Camp Lechugilla Ventures Mr. and Mrs. John C. Moorman Marsh Wortham Mr. Charles Hollimon McNelis + Associates Mr. Richard McSwain Mr. Sean B. McNelis
31
Yantis Company Mr. Todd Compton Mr. Mike Yantis Zachry Group Mr. Rode Moore Mr. David Schwab
The
ARGYLE
T
Substance and Style
he Argyle is a stately mansion in Alamo Heights that stands as a symbol of a rich past and an inspirational purpose: to support, encourage and foster scientific discovery at Texas Biomed. The private club is the platform for a decades-old relationship between Texas Biomed and those who give their time and money to support the Institute. Each member of The Argyle helps fund the future of research with annual contributions to advance the studies conducted by Texas Biomed scientists.
In 2018, The Argyle celebrated a second year with the status of Distinguished Club. This prestigious designation from BoardRoom magazine is a reflection of the excellent member experience which resulted in increased club membership and club usage. Roughly 4% of the 4,000 private clubs nationwide have an active waitlist and The Argyle is one of them. Lectures from scientists at Texas Biomed drew crowds during 2018, increasing the level of club engagement. During the Fireside Chats, audiences learned about many headline-making topics including “The Buzz About Zika: New Cautionary Research” and “100 Years Since the Spanish Flu Pandemic: Are We Safer?” Member contributors — the Coates Charitable Foundation and Elizabeth Huth Coates Charitable Foundation — are funding some stylish upgrades to the 19th century building. The Argyle is focused on the future with the creation of a new addition — the Coates Tavern — which will become one of the most beautiful and desirable business casual bars in San Antonio and beyond. In an effort to improve the experience of club members, 2018 saw an investment from a generous donation from Ron and Karen Herrmann and their family that will improve access and provide new parking. With eyes trained on the future, The Argyle is expanding the club’s capacity by 15 percent and attracting a younger demographic. With substance and style, this warm and inviting venue is on track to provide excellent dining in unique surroundings for decades to come.
32
33
Officers of the Institution and Senior Administrators President and Chief Executive Officer Larry Schlesinger, M.D.
Vice President for Research Joanne Turner, Ph.D.
Vice President for Finance and Administration and Chief Financial Officer Bruce Edwards
Vice President for Advancement and Public Relations Corbett Christie
Vice President for Information Technology and Chief Technology Officer John M. Heaner Director, Southwest National Primate Research Center Deepak Kaushal, Ph.D.
Acknowledgments CREDITS
Copyright © 2018 Texas Biomedical Research Institute P.O. Box 760549 San Antonio, Texas 78245
Lisa Cruz, Assistant Vice President for Communications, Editor
The 2018 Annual Report is a publication of the Texas Biomedical Research Institute.
Jeffrey Heinke Design, Design
*Board of Trustees and Senior Administrators listed for 2018-2019
Wendy Rigby, Media and Communications Specialist, Writer and Assistant Editor Callie Rainosek, Graduate Writing Intern for Deepak Kaushal, Ph.D. and Community Outreach
PHOTOGRAPHY Josh Hushkin, pp 6, 9, 13, 18 Wendy Rigby, p 16 Jeffrey Heinke, pp 32-33 File photos, all other pages
TEXAS BIOMEDICAL RESEARCH INSTITUTE P.O. BOX 760549 SAN ANTONIO, TEXAS 78245 www.txbiomed.org 210.258.9400